Oppenheimer analyst Suraj Kalia raised the price target on Edwards Lifesciences (NYSE: EW) to $122.00 (from $120.00) while maintaining an ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE